1 / 43

N-3 Omega-The Miracles of Today’s Nutrition. What about future.?

N-3 Omega-The Miracles of Today’s Nutrition. What about future.? . Dr. Ugur Gogus Middle East Technical University Vocational School of Higher Education Tel: +903122103653 Fax:+903122101239 gugur@metu.edu.tr.

benjamin
Télécharger la présentation

N-3 Omega-The Miracles of Today’s Nutrition. What about future.?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. N-3 Omega-The Miracles of Today’s Nutrition. What about future.? Dr. Ugur Gogus Middle East Technical University Vocational School of Higher Education Tel: +903122103653 Fax:+903122101239 gugur@metu.edu.tr

  2. The very long chain polyunsaturated fatty acids C18, C20, C22 Health

  3. ω15 12 9 COOH Alpha-linolenic acid (omega -3) 12 9 COOH Linoleic acid (omega-6) Arachidonic acid 14 the highest double bond locant 20 total C # 20-14:6(ω6) Oleic acid 18- 9: 9(ω9) ω

  4. ω15 12 9 COOH Alpha-linolenic acid (omega -3) 12 9 COOH Linoleic acid (omega-6) Prostaglandins blood vessels blood circulation body functions ω

  5. n-6 omega PUFAs Linoleic acid(LA) Arachidonic acid(AA) PGE2; TXA2 Leukotriene B4IL-2 IL-6 TNF IL-1 neutrophil recruitment immunosuppressive free oxygen radicals vascular permeability platelet aggregation odema thrombogenesis and inflammation

  6. EFA cholesterol cytochrome P450 Brain AA(n-6) steroid hormone LN(n-3) Dihomo α-LN(n-3) Sugar transfer CTH hormone LA(n-6) reduce PGE2; LTB4 IL-2 IL-6 TNF TXA2 IL-1 produce awakening neutrophil rec. Vasc.perm, platelet agg, odema 1 series eicosanoids PGE3 Inflammation PGE1 PGD2 PGI3 Sleep promoter reduce EPA(C20:5)&DHA(C22:6) TXA3 + LTB5

  7. AA% AA/LN conversion rate inflammation dihomo α linolenic acid (LN)%

  8. TNF n-3 omega restorationT-suppressor cell amount antiinflammatory effect eczema psoriasis rheumatoid arthritis IBD Chron’s disease

  9. Stenson et al.(1992)/Hawthorne et al.(1992) n-3 Omega; 5.4-4.5g Colon mucosa post operative healing amount ??? oxidation ??? Vit E

  10. AA(n-6) LA(n-6) PGE2 IL-1 LTB4 TNF OFR Hypercholesterolemic atherosclerosis

  11. AA(n-6) LA(n-6) PGE2 IL-1LTB4TNF OFRHypercholesterolemic atherosclerosis

  12. n-3 omega oxidation(7.7 g/daily) Oxidation of red blood cells LDL oxidation (Nardini, 1995) No difference(Brude et al. 1997) Are n-3 omega fatty acids oxidants or antioxidants?

  13. Se, carotenoid Cancer Dietary fat Obesity Na Hypertension alcohol Stroke n-3 omega CHD

  14. n-3 omega(5,4 g/day) PGE2 & thromboxanes thrombosis,fibrilation & clot formation CH amount HDL

  15. Schacky et al(1999) 2 year follow up n-3 omega 3 g/70 Kg/7day LDL VLDL (Lu, Windsor and Harris, 1999) CH VLDL HDL (Rader 2003; Barbeau et al. 1997; Allman et al. 2002; Liu, Wallin & Saldeen, 2001) Protein kinase C NO (Schoene 2001; El-seweidy et al. 2002)

  16. n-3 omegacreatin phosphokinaseMI Saturated fat(coconut) MI Nageswari,Banerjee & Menon 1999)

  17. prevention in post myocardial infarction n-3 omega ischemia-induced aryhtmias <3 g/day EPA&DHA GRAS Lee and Lip(2003) Leaf et al(2003)

  18. n-6 omega & n-3 omega PCB Linoleic acid endothelial cell wall Slim et al.(2001)

  19. n-3 omega NADPH oxidase Cellular protection Immun system defense

  20. Diabetes Mellitus plasma glucose fructosamine triglyseride LDL HDL NO IL-1 & TNF n-3 omega LDL IL-1 & TNF serum glucose? (El-seweidy et al.2002; Gavia et al. 2003)

  21. n-3 omega Platelet aggregation bile flow kidney (Levy & Herzberg 1996)

  22. EPA TNF weight gain (Fish oil & soy bean; Fish oil) tumorigenesis Colorectal cancer flaxseed Pancreas cancer fish oil soy oil olive oil PGE2 canola oil (Gavia et al. 2003; Gogos et al. 1998; Barber et al. 1999: Gavia et al. 2003; Troyer& fernandes, 1996; Denmark-Wahnefried et al. 1998)

  23. Phospholipids + PGE2 • Depression • Stress • Postpartum depression • Alzheimer • Parkinson • MS • Schizophrenia • (Horrobin et al. 2002; Maes et al. 1993; Song et al. 1998;Hibbeln, 1998; Edwars et al. 1998; Peet et al. 1998; Furukawa et al. 2002; Horribin et al. 2001)

  24. Omega 6 / Omega 3 • 10/1 • 15/1 16.7/1 • 2.5/1 colorectal cancer • 4/1 no effect • 2-3/1 rheumatoid arthritis • 5/1 asthma • (Simopoulos AP, 2002)

  25. Flax oil 9% Sat. Fat 20% Mono Fat 17% Omega-6 54% Omega-3 Grapeseed oil 10% Sat. Fat 17% Mono. Fat 73% Omega-6 Trace Omega-3 Pumpkin Oil 9% Sat. Fat 34% Mono. Fat 42% Omega-6 15% Omega-3 Canola Oil 6% Sat. Fat 58% Mono. Fat 26% Omega-6 10% Omega-3Safflower Oil 9% Sat. Fat 13% Mono. Fat 78% Omega-6 Trace% Omega-3Sunflower Oil 11% Sat. Fat 20% Mono. Fat 69% Omega-6 -0% Omega-3Sesame Oil 15% Sat. Fat 46% Mono. Fat 41% Omega-6 0% Omega-3Corn Oil 13% Sat. Fat 25% Mono. Fat 61% Omega-6 1% Omega-3 • Olive Oil 14% Sat. Fat 77% Mono. Fat 8% Omega-6 1% Omega-3 • Soybean Oil 15% Sat. Fat 24% Mono. Fat 54% Omega-6 7% Omega-3 • Walnut Oil 16% Sat. Fat 28% Mono. Fat 51% Omega-6 5% Omega-3Peanut Oil 18% Sat. Fat 48% Mono. Fat 34% Omega-6 0% Omega-3Lard 41% Sat. Fat 47% Mono. Fat 11% Omega-6 1% Omega-3Chicken Fat 31% Sat. Fat 47% Mono. Fat 21% Omega-6 1% Omega-3Beef Fat 52% Sat. Fat 44% Mono. Fat 3% Omega-6 1% Omega-3Butterfat 66% Sat. Fat 30% Mono. Fat 2% Omega-6 2% Omega-3Coconut Oil 92% Sat. Fat 6% Mono. Fat 2% Omega-6 0% Omega-3Palm Oil 51% Sat. Fat 39% Mono. Fat 10% Omega-6 0% Omega-3

  26. α linolenic acid Fat content/α linolenic acid Fat content(g/100g) / α-linolenic acid(g/100g) : Butter 83.2 1.20 69.3 Lard 100.0 0.98 102.04 Linseed oil 100.0 54.2 1.84 Soybean oil 100.0 7.70 12.98 Rapseed oil 100.0 9.15 10.93 Walnut oil 100.0 13.5 7.40 Olive oil 100.0 0.86 625 Vegetable oil 80.0 2.40 33.3 Almonds 54.1 0.26 208.07 Hazelnut 61.6 0.15 410.6 Walnuts 62.5 6.80 9.19 Kale 0.90 0.35 2.57 Lettuce 0.22 0.07 3.14 Parsley 0.36 0.12 3.00 Potato 0.11 0.02 5.5 Cauliflower 0.18 0.10 1.8 Spinach 0.30 0.13 2.31 White cabbage 0.20 0.09 2.22 Wheat bran 4.65 0.16 29.06

  27. Fat content EPA(g/100g) DHA(g/100g) fat content/EPA(g/100g)+DHA(g/100g) fat content(g/100g) EPA+DHA(g/100g) fat content/EPA+DHA(g/100g) Eel 24.5 0.83 29.51 Hering 17.8 2.72 6.54 Sprat 16.6 3.23 5.14 Tuna 15.5 3.37 4.60 Salmon 13.6 2.86 4.76 Mackerel 11.9 1.75 6.8 Carp 4.8 0.30 16 Sardine 4.5 1.39 3.24* Swordfish 4.4 1.79 2.45* Trout 2.7 0.59 4.58 Halibut 1.7 0.51 3.33* Cod 0.6 0.18 3.33* Haddock 0.6 0.16 3.75* Lobster 1.9 0.20 9.5 Shrimp 1.4 0.30 4.66 Mussels 1.4 0.15 9.33 Anchovy 2.3 0.50 4.60 Sardine 13.9 2.44 5.70

  28. Which fish for high Omega 3 Consumer education & correct information

  29. Which tablet & nutrition for consumer health??? Cinnamon Garlic Parsley Ginkgo bloba Tebocan Cumadin Aspirin/coraspirin Ginger Omega 3

  30. Infant nutrition/upto day 42 n-3 omega PUFAs pyschomotor + birthweight + N balance breast milk supl. with omega 3 and its effect??? (Woltil et al. 1999;Hayashi et al. 1999; Morley. 1998)

  31. Omega & meat industry Peroxide poultry fed with 8-12% fish meal (O’Keefe, Proudfoot & Ackman, 1995) No change lamb oxidative stress (Ponnampalam et al, 2001) Oxidative or nonoxidant or no change for meat products, which?? Enrichment of meat products with n-3 Ω(Raes, Smet & Demeyer, 2003) What about serum CH & n-3Ω levels followed by consumption.??

  32. No study on bone health!!! Only; lenght growth rats, fed with n-3Ω vertebral peak load (Sirois, Cheung & Ward, 2003)

  33. Application points of n-3 Ω Aerospace industry Cardiovascular disease; atherosclerosis, athrial fibrilosis, thrombose & emboly Cancer (esp in gastrointestinal org.) Diabetes type 2 Depression&stress Inflammation; crohn’s disease, rheumatoid arthritis, asthma, MS, chronic glomerular disease, erythematıosus, eczema, psoriasis, IBD) Infant nutrition Pre/post operative periods in surgery Alzheimer

  34. Questions; 1 What amount DHA&EPA supl. for Which DHA&EPA metabolic serum levels ? • Initial n-3/n-6 omega serum levels in the patient • The DHA/EPA amount in supplementation(from food or tablet)

  35. Most accepted recommend?(by FAO/WHO)(Trautwein 2001) • 5-10:1(n-6/n-3) • 10/1 no effect • 15/1 16.7/1 • 2.5/1 colorectal cancer • 4/1 no effect • 2-3/1 rheumatoid arthritis • 5/1 asthma • (Simopoulos AP, 2002)

  36. Missing application points; • Bone&skleton health • Consumer education and correct dose • Oxidation or antioxidation capacity • Meat hygine and nutrition • Sport industry • Cosmetic industry

  37. REFERENCES • Ackman, G. R. A question of balance in parenteral nutrition: have we overlooked the importance of w-6 and w-3 fatty acids.?. Nutrition. 2001; 17(11-12): 976-977. • Allman, M. A., Pang, D., Mnutr, K. M. K., Hall, D. F. & Favaloro, E. Cardiovascular risk factors and dietary plant omega-3 verus omega-6 fatty acids. Journal of the American Dietetic Association. 1996; 96(9):A75. Suppl:1. • Arkhipenko, Yu. V. & Sazontova, T. G. Mechanisms of the cardioprotective effect of a diet enriched with w-3 polyunsaturated fatty acids. Pathophysiology. 1995; 2(3): 131-140. • Arkhipenko, Yu. V. & Sazontova, T. G. Mechanisms of the cardioprotective effect of a diet enriched with w-3 polyunsaturated fatty acids. Pathophysiology. 1995; 2(3): 132. • Bajpai, P. & Bajpai, P. K. Eicosapentaenoic acid (EPA) production from microorganisms: a review. Journal of Biotechnology. 1993; 30(2):161-183. • Baker, D. G., Krauker, G. A. T. & Laposata, R. B. Z. Suppression of human synovial cell proliferation by dihomo  linolenic acid. Arthritis Rheum. 1989; 32:1273-1281. • Barbeau, M. L., Klemp, K. F., Guyton, J. R. & Rogers, K. A. Dietary fish oil. Influence on lesion regression in the porcine meodel of atherosclerosis. Atheriosclerosis, Thrombosis, and Vascular Biology. 1997; 17(4):688-694. • Barber, M. D., Ross, J. A., Vos, A. C., Tisdale, M. J. & Fearon, K. C. H. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br. J. Cancer. 1999; 81(1): 80-86. • Bartoli, G. M., Palozza, P., Luberto, C., Franceschelli, P. & Piccioni, E. Biochemical and Biophysical Research communications. 1995; 213(3):881. • Belluzzi, A. N-3 and n-6 fatty acids for the treatment of autoimmune diseases. Eur. J. Lipid Sci. Technol. 2001; 103:399. • Braga, M., Gianotti, L., Vignali, A. & Carlo, D. V. Immunonutrition in gastric cancer surgical patients. Nutrition. 1998; 14(11-12):831-835. • Brude, L. R., Drevon, C. A., Hjerman, I., Seljeflot, I. & Nenseter, M. S. Peroxidation of low density lipoprotein from male hyperlipidemic smokers suplied with omega-3 fatty acids and antioxidants. Atherosclerosis. 1997; 134(1-2):220. • Charalambos, A., Gogos, M. D., Ginopoulos, P. et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer.1998; 82(2): 395-402. • Clarke, L. H., Clarke, C. R. & Lippman, M. The inluence ofmaternal diet on breast cancer risk among female offspring. Nutrition. 1999; 15(5): 392-401. • Denmark-Wahnefried, W., Price, D. T., Polacik, T. J.et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery:exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic fetaures. Urology. 2001; 58(1):47-52. • Eder, K. & Brandsch, C. The effects of fatty acid composition of rapeseed oil on plasma lipids and oxidative stability of low-density lipoproteins in cholesterol-fed hamsters. European Journal of Lipid Science and Technology. 2002; 104(1):3 • Edwards, R., Peet, M., Shay, J. & Horrobin, D. Omega-3 polyunsaturated fatty acids in the diet and in the red blood cell membranes od depressed patients. J. Affect Disord. 1998; 48:153-155. • El-seweidy, M. M., El-swefy, S. E., Ameen, R. S. & Hashem, R. M. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz(streptozotocin)diabetic rats. Pharmacological Research. 2002; 45(5):395-398. • El-seweidy, M. M., El-swefy, S. H., Ameen, R. S. & Hashem, R. M. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in diabetic rats. Pharmacological Research. 2002; 45(5):391-398.

  38. Emmanuel, C. O. & Hubbard, V. S. Essential fatty acids (EFA): Role in pancreatic hormone release and concomitant metabolic effect. The Journal of Nutritional Biochemistry. 1993; 4(9): 498. • Endres, S., Ghorbani, R., Kelley, VE., Georgilis, K., Lonnemann, G. & Van der Meer, JWM. The effect of dietary supplementation with (n-3)polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 1989; 320:265-73. • Furukawa, K., Yamamori, H., Tukagi, K. et. al. Influences of soybean oil emulsion on stress response and cell-mediated immune function on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutriition. 2002; 18(3):235-239. • Gavia, H. M., Couto, C. R., Oyama, M. L. et. al. Diets rich in polyunsaturated fatty acids effect on hepatic metabolism in rats. Nutrition. 2003; 19(2): 144. • Gavia, H. M., Couto, C. R., Oyama, M. L. et. al. Diets rich in polyunsaturated fatty acids effect on hepatic metabolism in rats. Nutrition. 2003; 19(2): 148-149. • Gil, A. Polyunsaturated fatty acids and inflammatory diseases. Biomedicine & Pharmacotherapy. 2002; 56(8): 388-396. • Gogos, A. C., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, C. N. & Kalfarentzos, F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival dor reversily ill patients with generalized malignancy. Cancer. 1998; 82(2):395-402. • Griffiths, M. A. Inflammatory bowel disease. Nutrition. 1998; 14(10):788-791. • Hawthorne, A. B., Daneshmend, T. K., Hawkey, C. J. et. al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 months randomized controlled trial. Gut. 1992; 33: 922-928. • Hayashi, N., Tashiro, T., Yamamori, H. et. al. Effect of intravenous w-6 and w-3 fat emulsions on nitrogen retension and protein kinetics in burned rats. Nutrition. 1999; 15(2):135-139. • Heine, J., Scheinichen, D., Jaeger, K., Andre, M. & Leuwer, M. Invitro influence of parenteral lipid emulsions on the respiratory burst of neutrophils. Nutrition. 1999; 15(7-8):540-545. • Heininger, K. A unifying of Alzheimer’s disease. III. Risk Factors. Human Psychopharmacology. Clin. Exp. 2000; 15:1. • Hibbeln, J. R. Seafood consumption, the DHA content of mother’s milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. Journal of Affective Disorders. 2002; 69(1-3):15-29. • Hibbeln, JR. 1998. Fish consumption and major depression. Lancet. 351:1213. • Horrobin, F. D. Phospholipid metabolism and depression:the possible roles of phospholipase A2 and coenzme A-indeoendent transacylase. Human Psychopharmacology:Clinical and Experimental. 2001; 16(1):45-52. • Horrobin, D. F., Jenkins, K., Bennett, C. N. & Christie, W. W. Eicosapentaenoic acid and arachidonic acid:colloboration and not antagonism is the key to biological understanding. Prostoglandins, Leukotriens and Essential Fatty Acids. 2002; 66(1):83-90. • Köller, M., Senkal, M., Kemen, M., König, W., Zumtobel, V. & Muhr, G. Impact of omega 3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clinical Nutrition. 2003; 22(1):59-64. • Kramer, H. J., Stevens, J., Grimminger, F. & Seeger, W. Fish oil fatty acids and human platelets. Dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochemical Pharmacology. 1996; 52(8): 1211-1214. • Kuhnlein, H. V., Yeboah, F., Sedgemore, M., Sedgemore, S. & Chan, H. M. Nutritional qualities of Ooligan Grease: A Traditional Food Fat of British Columbia First Nations. Journal of Food Composition and Analysis. 1996; 9(1):18-31.

  39. Kusunoki, M., Tsutsumi, K., Hara, T. et. al. Ethyl icosapentate(omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Metabolism. 2003; 52(1):30-34. • Leaf, A., Xiao, F. Y., Kang, X. J. & Billman, G. E. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacology&Therapeutics. 2003; 98(3):355-377. • Lee, KW. & Lip, GY. H. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM-AN Int. J. Of Medicine.2003; 96(7):465-480. • Levy, R. & Herzberg, G. R. Effects of a meal of fish oil or corn oil on bile flow and composition in rats previously adapted to diets containing fish oil or corn oil. Nutrition Research. 1996; 16(5):805-816. • Linseisen, J., Hoffmann, J., Lienhard, S., Jauch, K. W. & Wolfram, G. Antioxidant status of surgical patients receiving TPN with an n-3 fatty acid containing lipid emulsion supplemented with -tocopherol. Clinical Nutrition. 2000; 19(3): 177-178. • Linseisen, J., Hoffmann, J., Lienhard, S., Jauch, K.W. & Wolfram, G. Antioxidant status of surgical patients receiving TPN with an -3-fatty acid-containing lipid emulsion supplemented with -tocopherol. Clinical Nutrition. 2000; 19(3):183. • Liu, M., Wallin, R. & Saldeen, T. Effect of bread containing stable fish oil on plasma phospholipid fatty acids, triglycerides, HDL-cholesterol, and malondialdehyde in subjects with hyperlipidemia. Nutrition Research. 2001; 21(11):1403-1410. • Lox, C. D. The effects of dietary marine fish(omega-3 fatty acids)on coagulation profiles in men. General Pharmacology:The Vascular System. 1990; 21(2):241-246. • Lu, G., Windsor, S. L. & Harris, W. S. Omega-3 fatty acids after lipoprotein subfraction distributions and the in vitro conversion f very low density lipoproteins to low density lipoproteins. The Journal of Nutritional Biochemistry. 1999; 10(3): 151-158. • Maes, M., Stevens, WJ., Declerek, LS. et. al. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression:further evidence for an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17:241-255. • Maes, M., Verkerk, R., Vandoolaeghe, E. et. al. Serotonin-immune interactions in major depression:lower serum tryptophan as a marker of an immune-inflammatory response. EurArch Psychiatr Clin Neurosci. 1997; 247:154-161. • Morley, R. Nutrition and cognitive development. Nutrition. 1998; 14(10):752-754. • Nageswari, K., Banerjee, R. & Menon, V. P. Effect of saturated, w-3 and w-6 polyunsaturated fatty acids on myocardial infarction. The Journal of Nutritional Biochemistry. 1999; 10(6):338-344. • Nardini, M., D’Aquino, M. D., Gentili, V., DiFelice, M. & Scaccini, C. Dietary fish oil enhances plasma and LDL oxidative modification in rats. The Journal of Nutritional Biochemistry. 1995; 6(9):474-480. • Nitenberg, G. & Raynard, B. Nutritional support of the cancer patient: issues and dilemmas. Critical Reviews in Oncology/Hematology. 2000; 34(3): 137-168. • Nkondjock, A., Shatenstein, B., Maisonneuve, P. & Ghadirian, P. Specific fatty acids and human colorectal cancer: an overview. Cancer detection and Prevention. 2003; 27(1): 55-66 • O’Keefe, J. H. Jr. & Harris, W. S. From Inuit to implementation: Omega-3 fatty acids come of age. Mayo Clinic Proceedings. 2000; 75(6):607-610. • O’Keefe, S. F., Proudfoot, F. G. & Ackman, R. G. Lipid oxidation in meats of omega-3 fatty acid-enriched broiler chickens. Food Research International. 1995; 28(4): 151-161.

  40. Peet, M., Murphy, B., Shay, J. & Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol psychiatry. 1998; 43:317-319. • Ponnampalam, E. N., Trout, G. R., Sinclair, A. J., Egan, A. R. & Leury, B. J. Comparison of the color stability and lipid oxidative stability of fresh and vacuum packaged lamb muscle containing elevated omega-3 and omega-6 fatty acid levels from dietary manipulation. Meat Science. 2001; 58(2):151-161. • Prasad, K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997; 132(1): 69. • Puiggros, C., Chacon, P., Armadans, J. I., Clapes, J. & Planas, M. Effects of oleic-rich and omega-3 rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Clinical Nutrition. 2002; 21(1): 79-87. • Rader, D. J. Effects of nonstatin lipid drug therapy on high-density lipoprotein metabolism. The American Journal of Cardiology. Supl. 1. 2003; 91(7):18-23. • Raes, K., Smet, S, De. & Demeyer, D. Available on line 23 October 2003. Effect of dietary fatty acids as incorparation of long chain polyunsaturated fatty acids and conjugated linolenic acid in lamb, beef and pork meat: a review. Animal Feed Science and Technology, In Press, Corrected Proof. • Retterstol, K., Stugaard, M., Gorbitz, C. & Ose, L. Results of intensive long-term treatment of familial hypercholesterolemia. The American Journal of Cardiology. 1996; 78(12):1369-1374. • Rokka, T., Allen, K., Valaja, J. & Ryhanen, E.-L. The effect of a Camelina sativa enriched diet on the composition and sensory quality of hen eggs. Food Research International. 2002; 35(2-3):254-256. • Santoli, D., Phillips, P. D., Colt, T. L. & Zurier, R. B. Suppression of interleukin-2 dependent human T cell growth by E-series prostaglandins (PGE) and their precursor fatty acids:evidence for a PGE-independent mechanism of inhibition by the fatty acids. J. Clin. Invest. 1990; 35:424-432. • Sauci., Fahman & Kraut. Food Composition and Nutrition Tables, 5th. Ed. 1994. • Schacky, C., Angerer, P., Kothny, W., Theisen, K. & Mudra, H. The effect of dieatry omega-3 fatty acdis on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 1999; 130(7):561-562. • Schoene, N. W. Beyond deficiency:new roles for vitamins. Vitamin E and w-3 fatty acids:effectors of platelet responsiveness. Nutrition. 2001; 17(10):793-796. • Shoda, R., Matsueda, K., Yamato, S. & Umeda, N. Epidemiologic analysis of Chron disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of chron disease in Japan. Am. J. Clin. Nutr. 1996; 63(5):741-745. • Sidhu, K. S. Health benefits and potential risks related to consumption of fish or fish oil. Regulatory Toxicology and Pharmacology. 2003; 38(3):336 • Simopoulos, Ap., Kifer, RR. Martin, RE. & Barlow, SM. Health effects of w-3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet. 1991; 66:488-503. • Sirous, I., Cheung, A. M. & Ward, E. W. Biochemical bone strenght and bone mass in young male and female rats fed a fish oil diet. Prostaglandins, Leukotrienes and Essential fatty acids. 2003; 68(6):415-421. • Slim, R., Hammock, D. B., Toborek, M., Robertson, W. L., Newman, W. J., Morisseau, H. P. C., Watkins, A. B., Saraswathi, V. & Hennig, B. The role of Methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicology and Applied Pharmacology. 2001; 17(3): 184-193. • Song, C., Lin, A., Bonaccorso, S. et. al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep desorders and major depression. J. Affect Disord. 1998; 49:211-219.

  41. Stenson, W. F., Cort, D., Rodgers, J. et. al. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med.1992; 116:609-614. • Sweeney, C., Freeman, J., Gee, D. L. et. al. Changes in coronary heart disease risk among Japanese exchange students. Journal of American Dietetic Association. Supp:1. 1999; 99(9):A77. • Tapiero, H., Nguyen Ba, G., Couvreur, P. & Tew, K. D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomedicine & Pharmacotherapy. 2002; 56(5): 216. • Temple, J. N. Nutrition and disease:challenges of research design. Nutrition. 2002; 18(4):343. • Temple, N. J. Nutrition and disease:challenges of research design. Nutrition. 2002; 18(4):343-345. • Temple, NJ. Dietary fats and coronary heart disease. Biomedicine & Pharmacotherapy. 1996; 50(6-7):261-268. • Trautwein, E. A. N-3 Fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103: 47. • Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:45. • Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:51. • Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:52. • Troyer, D. & Fernandes, G. Nutrition and apoptosis. Nutrition Research. 1996; 16(11-12): 1959-1987. • Turner, D. N., Braby, L. A., Ford, J. & Lupton, R. J. Nutrition. Opportunities for nutritional amelioration of radiation of radiation-induced cellular damage. 2002; 18(10):904-912 • Villa, B., Calabresi, L., Chiesa, G., Rise, P., Galli, C. & Sirtori, C. R. Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacological Research. 2002; 45(6):475-478. • Wahlqvist, M. L. Nutritional pathways to coronary heart disease. Atherosclerosis. 1998;136(1):528. • Warriss, P. D. Fats. Meat Science. An Introductory Text. CABI Publishing, UK. 2001: 46. • Weber, P. & Raederstorff, D. Triglyceride lowering effect of omega-3 LC-polyunsaturated fatty acids-a review. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD. 2000; 10(1):28-37. • Woltil, H. A., Beusekom, C. M., Okken-Beukens, M., Schaafsma, A., Muskiet, F. A. J. & Okken, A. Development of low-birthweight infants at 19 months of age correlates with early intake and status of long chain polyunsaturated fatty acids. Prostaglandins, Lekotrienes and Essential Fatty Acids. 1999; 61(4): 235-241. • Wood, O. L., Spark, A. & Spark, A. Medical nutrition therapy guidelines for treating the breast cancer patient. Journal of the American Dietetic Association. 1996; 96(9): A35. Suppl: 1.

  42. Wojenski, C. M., Silver, M. J. and Walker, J. Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil. Biochimica et Biophysica Acta(BBA)-Lipids and Lipid Metabolism. 1991; 108(1):33-38. • Yahia, A. D., Madani, S., Savelli, L. J., Prost, J., Bouchenak, M. & Belleville, J. Dietary fish protein lowers blood pressure and alters tissue polyunsaturated fatty acid composition in spontaneously hypertensive rats. Nutrition. 2003; 19(4):342-346. • Yehuda, S., Rabinovitz, S. & Mostofsky, D. I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research. 1999; 56:565. • Yehuda, S., Rabinovitz, S. & Mostofsky, D. I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research. 1999; 56:566. • Zimmerman, J. Optimal nutrition for HIV/AIDS Welness. Journal of the American Dietetic Association. 1997; 97(9):A18 Suppl: 1 • Zyriax, B. C. & Windler, E. Dietary fat in the prevention of cardiovascular disease-a review. Eur. J. Lipid Sci. Technol. 2000; 355 Many thanks for all of you for your participation and listening☺ gugur@metu.edu.tr

More Related